Global Rivaroxaban Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Published: November 2016
No. of Pages: 111
    ReportsandReports

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

Scope of the Report:

This report focuses on the Rivaroxaban in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  • Bayer
  • J&J

Market Segment by Regions, regional analysis covers

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America, Middle East and Africa

Market Segment by Type, covers

  • 2.5 mg
  • 10 mg
  • 15 mg
  • 20 mg

Market Segment by Applications, can be divided into

  • Acute coronary syndrome (ACS)
  • Venous thromboembolism (VTE)

There are 13 Chapters to deeply display the global Rivaroxaban market.

Chapter 1, to describe Rivaroxaban Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Rivaroxaban , with sales, revenue, and price of Rivaroxaban , in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Rivaroxaban , for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Rivaroxaban market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Rivaroxaban sales channel, distributors, traders, dealers, appendix and data source.

Published By: Global Info Research
Product Code: Global Info Research1930


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • 2017-2022 Global Top Countries Vitamin B12 Market Report

    This report studies Vitamin B12 in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturer...

  • Asia-Pacific Octreotide Acetate Market Report 2017

    In this report, the Asia-Pacific Octreotide Acetate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacif...

  • Asia-Pacific Nanostructured Drug Market Report 2017

    In this report, the Asia-Pacific Nanostructured Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Paci...

  • Asia-Pacific Injectable Drug Delivery Market Report 2017

    In this report, the Asia-Pacific Injectable Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia...

  • Asia-Pacific Heparin Market Report 2017

    In this report, the Asia-Pacific Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into sev...

  • EMEA (Europe, Middle East and Africa) Unfractionated Heparin Market Report 2017

    In this report, the EMEA Unfractionated Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Euro...

  • EMEA (Europe, Middle East and Africa) Polymerases Market Report 2017

    In this report, the EMEA Polymerases market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Mid...

  • EMEA (Europe, Middle East and Africa) Oral Anticoagulant Market Report 2017

    In this report, the EMEA Oral Anticoagulant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, ...

  • EMEA (Europe, Middle East and Africa) Low Molecular Weight Heparin Market Report 2017

    In this report, the EMEA Low Molecular Weight Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA int...

  • EMEA (Europe, Middle East and Africa) Dialysate Market Report 2017

    In this report, the EMEA Dialysate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middl...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: